Načítá se...
Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
Severe acute respiratory syndrome coronavirus 2 has spread across the globe affecting more than 10 million people as of August 2020. With the pandemic spreading at such an alarming rate, a lot of efforts are in the process of identification of an effective treatment at it’s earliest. Hydroxychloroqu...
Uloženo v:
| Vydáno v: | Eur J Rheumatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medical Research and Education Association
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8133889/ https://ncbi.nlm.nih.gov/pubmed/33044166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2020.20174 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|